These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20305306)

  • 1. [The effects of duloxetine on beta-actin stress response in rat brain].
    Szücs S; Pákáski M; Domokos A; Kálmán J; Kálmán S; Garab D; Penke B; Szabó G; Janka Z; Kálmán J
    Neuropsychopharmacol Hung; 2010 Mar; 12(1):301-7. PubMed ID: 20305306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute and chronic stress induced changes in gene transcriptions related to Alzheimer's disease].
    Sántha P; Pákáski M; Fazekas O; Szucs S; Fodor EK; Kálmán J; Kálmán S; Szabó G; Janka Z; Kálmán J
    Ideggyogy Sz; 2012 May; 65(5-6):195-200. PubMed ID: 22724288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of immobilization stress and sertindole on the expression of APP, MAPK-1 and beta-actin genes in rat brain].
    Kállmán J; Pákáski M; Szucs S; Kálmán S; Fazekas O; Santha P; Szabó G; Janka Z; Kálmán J
    Ideggyogy Sz; 2012 Nov; 65(11-12):394-400. PubMed ID: 23289174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [9-hydroxy-risperidone (9OHRIS) prevents stress-induced β-actin overexpression in rat hippocampus].
    Kalman S; Pakaski M; Szucs S; Kalman J; Fazekas O; Santha P; Szabo G; Janka Z; Kalman J
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):425-31. PubMed ID: 20962362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
    Gould GG; Javors MA; Frazer A
    Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake.
    Mannari C; Origlia N; Scatena A; Del Debbio A; Catena M; Dell'agnello G; Barraco A; Giovannini L; Dell'osso L; Domenici L; Piccinni A
    Cell Mol Neurobiol; 2008 May; 28(3):457-68. PubMed ID: 18172756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
    Kasamo K; Blier P; De Montigny C
    J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
    Katoh A; Eigyo M; Ishibashi C; Naitoh Y; Takeuchi M; Ibii N; Ikeda M; Matsushita A
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1067-75. PubMed ID: 7891317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
    Rueter LE; De Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
    Rueter LE; Kasamo K; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
    Jones CK; Peters SC; Shannon HE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of duloxetine, a norepinephrine and serotonin reuptake inhibitor, on sneeze-induced urethral continence reflex in rats.
    Miyazato M; Kaiho Y; Kamo I; Chancellor MB; Sugaya K; de Groat WC; Yoshimura N
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F264-71. PubMed ID: 18480175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.
    Thor KB; Katofiasc MA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):1014-24. PubMed ID: 7636716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.
    Bymaster FP; Lee TC; Knadler MP; Detke MJ; Iyengar S
    Curr Pharm Des; 2005; 11(12):1475-93. PubMed ID: 15892657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.